Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Other Working Capital history
Currency unavailable · from the cash flow
No Other Working Capital data reported for this period type.
Other Working Capital vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $15.67M USD | -52.0% | — | 211.8% |
| LTM Jun 2026 | $13.91M USD | +127.8% | +31.7% | 4.9% | |
| LTM Mar 2026 | $12.8M USD | -157.3% | +91.3% | 153.0% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $7.46M USD | +332.8% | +54.7% | — |
| LTM Mar 2026 | $6.51M USD | -4.9% | -59.0% | — | |
| LTM Sep 2026 | $3.08M USD | -116.3% | +68.1% | 3.4% | |
| LTM Mar 2026 | $1.92M USD | +150.9% | -48.7% | 0.8% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -4.9% | +43.2% | 4.9% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.